FDA Inspection 843335 — Repligen Corporation

Repligen Corporation — FEI 1625657

The FDA completed an inspection of Repligen Corporation on Aug 7, 2013 in Irving, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Aug 7, 2013
Fiscal Year
2013
Product Type
Devices
Project Area
Compliance: Devices
Location
Irving, TX (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.